FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Scott Antonia

Research Profile

Anatomy

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Cristina Iclozan; Scott J Antonia; Dung-Tsa Chen; Alberto Chiappori; Dmitry I Gabrilovich
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.
Hatem Soliman; Harris G Yfantis; Scott J Antonia; Marylin M Bui; Tiffany H Dorsey; Jimmy Fulp; Farah Khalil; Dong H Lee; Ji-Hyun Lee; Alexis Lopez; Bhupendra Rawal; Stefan Ambs
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry.
Je-In Youn; Scott J Antonia; Pingyan Cheng; Michelle Collazo; Thomas Condamine; Mayer Fishman; Pedro Horna; Vinit Kumar; Judith C McCaffrey; Yulia Nefedova; Amod Sarnaik; Eduardo Sotomayor; alejandro villagra; Dmitry I Gabrilovich
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Scott Antonia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cristina Iclozan; Scott J Antonia; Dung-Tsa Chen; Alberto Chiappori; Dmitry I Gabrilovich
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer.
Cancer immunology, immunotherapy : CII 2013;62(5):909-18.
2013: Hatem Soliman; Harris G Yfantis; Scott J Antonia; Marylin M Bui; Tiffany H Dorsey; Jimmy Fulp; Farah Khalil; Dong H Lee; Ji-Hyun Lee; Alexis Lopez; Bhupendra Rawal; Stefan Ambs
Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry.
Cancer immunology, immunotherapy : CII 2013;62(5):829-37.
2013: Je-In Youn; Scott J Antonia; Pingyan Cheng; Michelle Collazo; Thomas Condamine; Mayer Fishman; Pedro Horna; Vinit Kumar; Judith C McCaffrey; Yulia Nefedova; Amod Sarnaik; Eduardo Sotomayor; alejandro villagra; Dmitry I Gabrilovich
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.
Nature immunology 2013;14(3):211-20.
2012: Ali McBride; Eric B Haura; Scott J Antonia; Dawn Goetz
Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.
Journal of pharmacy practice 2012;25(4):477-85.
2012: Suzanne Topalian; JON WIGGINTON; Haiying Xu; Janis M Taube; Shruti Agrawal; Robert A Anders; Scott J Antonia; Michael B Atkins; Julie R Brahmer; Richard D Carvajal; Lieping Chen; Charles G Drake; Scott N Gettinger; Ashok Gupta; F Stephen Hodi; Leora Horn; Maria Jure-Kunkel; Georgia D Kollia; Alan J Korman; Philip D Leming; David F McDermott; Daniel McDonald; Tracee L McMiller; Drew M Pardoll; John D Powderly; WILLIAM SHARFMAN; David C Smith; Jeffrey A Sosman; David R Spigel; Mario Sznol
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
The New England journal of medicine 2012;366(26):2443-54.
2012: Steven Eric Finkelstein; Scott J Antonia; Matt Biagoli; Tian Chuang; Mary Dunn; Mary-Jane Farmello; Dmitry Gabrilovich; Randy Heysek; William Janssen; Loveleen Kang; Julio Pow-Sang; Francisco Rodriguez; Jacob Scott; John Seigne; Ravi Shankar; Renee Smilee; Javier F Torres-Roca; Mayer Fishman
Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy.
Immunotherapy 2012;4(4):373-82.
2012: Steven Eric Finkelstein; Mayer Fishman; Dmitry Gabrilovich; Scott J Antonia; Anthony P Conley; Alberto Chiappori
Cellular immunotherapy for soft tissue sarcomas.
Immunotherapy 2012;4(3):283-90.
2012: Steven E Finkelstein; Jamil Ahmed; Scott J Antonia; Claudia Berman; Marilyn M Bui; David Cheong; Matthew J Cotter; Ricardo J Gonzalez; Randy V Heysek; Cristina Iclozan; William Janssen; Brianna C Lenox; G Douglas Letson; David R Noyes; Rupal Ramakrishnan; Vernon K Sondak; Jonathan S Zager; Dmitry I Gabrilovich
Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.
International journal of radiation oncology, biology, physics 2012;82(2):924-32.
2011: S Tariq Mahmood; Carlos E Vigil; Xiuhua Zhao; Samuel Agresta; Scott J Antonia; Ciara E Calitri; Gina D'Amato; Michelle Dean; Christopher Garrett; Gang Han; Michael J Schell; Alberto Chiappori
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma.
International journal of cancer. Journal international du cancer 2011;129(8):1963-9.
2011: Terri B Hunter; Kimberly A Luddy; Neil J Manimala; Tracy Catlin; Scott J Antonia
Paclitaxel and TRAIL synergize to kill paclitaxel-resistant small cell lung cancer cells through a caspase-independent mechanism mediated through AIF.
Anticancer research 2011;31(10):3193-204.
2010: Jens Rüter; Scott J Antonia; Howard A Burris; Richard D Huhn; Robert H Vonderheide
Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors.
Cancer biology & therapy 2010;10(10):983-93.
2010: Alberto Chiappori; Hatem Soliman; William E Janssen; Scott J Antonia; Dmitry I Gabrilovich
INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect.
Expert opinion on biological therapy 2010;10(6):983-91.
2010: Jennifer L Giglia; Scott J Antonia; Lawrence B Berk; Salvador Bruno; Sophie Dessureault; Steven E Finkelstein
Systemic therapy for advanced hepatocellular carcinoma: past, present, and future.
Cancer control : journal of the Moffitt Cancer Center 2010;17(2):120-9.
2010: Eric Haura; Tawee Tanvetyanon; Alberto Chiappori; Charles Williams; George Simon; Scott J Antonia; Jhanelle Gray; Sharon Litschauer; Leticia Tetteh; Anthony Neuger; Lanxi Song; Bhupendra Rawal; Michael J Schell; Gerold Bepler
Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(8):1387-94.
2009: Jose Ortega; J Michael Hayes; Scott J Antonia
Hepatic portal venous gas in a patient with metastatic non-small cell lung cancer on bevacizumab therapy: a case report and review of the literature.
Cancer chemotherapy and pharmacology 2009;65(1):187-90.
2008: George R Simon; Martine Extermann; Alberto Chiappori; Charles C Williams; Mubeena Begum; Rachna Kapoor; Eric Haura; Roohi Ismail-Khan; Michael J Schell; Scott J Antonia; Gerold Bepler
Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older.
Cancer 2008;112(9):2021-9.
2008: Alberto Chiappori; Eric Haura; Francisco A Rodriguez; David Boulware; Rachna Kapoor; Anthony M Neuger; Richard M Lush; Barbara Padilla; Michelle Burton; Charles Williams; George Simon; Scott J Antonia; Daniel M Sullivan; Gerold Bepler
Phase I/II study of atrasentan, an endothelin A receptor antagonist, in combination with paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(5):1464-9.
2008: Mayer Fishman; Terri B Hunter; Hatem Soliman; Patricia Thompson; Mary Dunn; Renee Smilee; Mary Jane Farmelo; David R Noyes; John J Mahany; Ji-Hyun Lee; Alan Cantor; Jane Messina; John Seigne; Julio Pow-Sang; William Janssen; Scott J Antonia
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2008;31(1):72-80.
2007: George Simon; Anupama Sharma; Xueli Li; Todd Hazelton; Frank Walsh; Charles Williams; Alberto Chiappori; Eric Haura; Tawee Tanvetyanon; Scott J Antonia; Alan Cantor; Gerold Bepler
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(19):2741-6.
2007: T B Hunter; Marwan Alsarraj; R P Gladue; V Bedian; Scott J Antonia
An agonist antibody specific for CD40 induces dendritic cell maturation and promotes autologous anti-tumour T-cell responses in an in vitro mixed autologous tumour cell/lymph node cell model.
Scandinavian journal of immunology 2007;65(5):479-86.
2007: GILBERTO LOPES; Alberto Chiappori; George Simon; Eric Haura; Dan Sullivan; Scott J Antonia; Michael Langevin; Richard M Lush; Caio Rocha Lima
Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
Cancer 2007;109(7):1413-9.
2007: Robert H Vonderheide; Keith T Flaherty; Magi Khalil; Molly S Stumacher; David L Bajor; Natalie A Hutnick; Patricia Sullivan; J Joseph Mahany; Maryann Gallagher; Amy Kramer; Stephanie J Green; Peter J O'Dwyer; Kelli L Running; Richard D Huhn; Scott J Antonia
Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(7):876-83.
2007: Sophie Dessureault; David Noyes; David Lee; Mary Dunn; William Janssen; Alan Cantor; Eduardo M Sotomayor; Jane Messina; Scott J Antonia
A phase-I trial using a universal GM-CSF-producing and CD40L-expressing bystander cell line (GM.CD40L) in the formulation of autologous tumor cell-based vaccines for cancer patients with stage IV disease.
Annals of surgical oncology 2007;14(2):869-84.
2006: Noweeda Mirza; Mayer Fishman; Ingo Fricke; Mary Dunn; Anthony M Neuger; Timothy J Frost; Richard M Lush; Scott J Antonia; Dmitry I Gabrilovich
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.
Cancer research 2006;66(18):9299-307.
2006: George R Simon; Richard M Lush; Jana Lynn Dawson; Leticia Tetteh; Charles Williams; Alan Cantor; Scott J Antonia; Christopher Garrett; Caio Rocha Lima; Mayer Fishman; Daniel M Sullivan; Pamela N Munster
Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial.
Molecular cancer therapeutics 2006;5(8):2130-7.
2006: Kensuke Ohashi; Gen Kobayashi; Sandy Fang; Xiaoyan Zhu; Scott J Antonia; Arthur M Krieg; Anthony D Sandler
Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
Journal of pediatric surgery 2006;41(8):1361-8.
2006: Scott J Antonia; Noweeda Mirza; Ingo Fricke; Alberto Chiappori; Patricia Thompson; Nicholas Williams; Gerold Bepler; George Simon; William Janssen; Ji-Hyun Lee; Kerstin B Menander; Sunil Chada; Dmitry I Gabrilovich
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):878-87.
2005: Sophie Dessureault; Marwan Alsarraj; Susan McCarthy; Terri Hunter; David Noyes; David Lee; Jennifer Harkins; John Seigne; Ronald Jennings; Scott J Antonia
A GM-CSF/CD40L producing cell augments anti-tumor T cell responses.
The Journal of surgical research 2005;125(2):173-81.
2005: Alberto Chiappori; George Simon; Charles Williams; Eric Haura; Caio Rocha Lima; Henry Wagner; Gerold Bepler; Scott J Antonia
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer.
Oncology 2005;68(4-6):382-90.
2004: Paulo C Rodriguez; David G Quiceno; Jovanny Zabaleta; Blair Ortiz; Arnold H Zea; M Blanca Piazuelo; Alberto Delgado; Pelayo Correa; Jason Brayer; Eduardo M Sotomayor; Scott J Antonia; Juan B Ochoa; Augusto C Ochoa
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.
Cancer research 2004;64(16):5839-49.
2004: David H Munn; Madhav D Sharma; Deyan Hou; Babak Baban; Jeffrey R Lee; Scott J Antonia; Jane L Messina; Phillip R Chandler; Pandelakis Koni; Andrew L Mellor
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes.
The Journal of clinical investigation 2004;114(2):280-90.
2004: Scott J Antonia; James J Mulé; Jeffrey S Weber
Current developments of immunotherapy in the clinic.
Current opinion in immunology 2004;16(2):130-6.
2004: Mayer Fishman; Scott J Antonia
Specific antitumour vaccine for renal cancer.
Lancet 2004;363(9409):583-4.
2003: Mayer N Fishman; Scott J Antonia
Cell-based immune therapy for metastatic renal cancer.
Expert review of anticancer therapy 2003;3(6):837-49.
2003: Jeffrey R Lee; Rory R Dalton; Jane L Messina; Madhav D Sharma; David M Smith; Russell E Burgess; Fermina M Mazzella; Scott J Antonia; Andrew L Mellor; David H Munn
Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma.
Laboratory investigation; a journal of technical methods and pathology 2003;83(10):1457-66.
2003: Eric Haura; Eduardo M Sotomayor; Scott J Antonia
Gene therapy for lung cancer.
Molecular biotechnology 2003;25(2):139-48.
2003: George R Simon; John Ruckdeschel; Charles Williams; Alan Cantor; Alberto Chiappori; Caio Rocha Lima; Scott J Antonia; Eric Haura; Henry Wagner; Lary Robinson; Eric Sommers; Michael Alberts; Gerold Bepler
Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution.
Cancer control : journal of the Moffitt Cancer Center 2003;10(5):388-95.
2003: Mayer Fishman; Scott J Antonia
Novel therapies for renal cell carcinoma--an update.
Expert opinion on investigational drugs 2003;12(4):593-609.
2003: Eric Haura; Eduardo M Sotomayor; Scott J Antonia
Gene therapy for lung cancer. An introduction.
Methods in molecular medicine 2003;75():529-43.
2002: David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip R Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
Science (New York, N.Y.) 2002;297(5588):1867-70.
2002: Maria Friberg; Ronald Jennings; Marwan Alsarraj; Sophie Dessureault; Alan Cantor; Martine Extermann; Andrew L Mellor; David H Munn; Scott J Antonia
Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection.
International journal of cancer. Journal international du cancer 2002;101(2):151-5.
2002: Scott J Antonia; John Seigne; Jose Diaz; Carlos Muro-Cacho; Martine Extermann; Mary Jane Farmelo; Maria Friberg; Marwan Alsarraj; J Joseph Mahany; Julio Pow-Sang; Alan Cantor; William Janssen
Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma.
The Journal of urology 2002;167(5):1995-2000.
2002: Maria G Sotomayor; Hua Yu; Scott J Antonia; Eduardo M Sotomayor; Drew M Pardoll
Advances in gene therapy for malignant melanoma.
Cancer control : journal of the Moffitt Cancer Center 2002;9(1):39-48.
2001: Mayer Fishman; John Seigne; Scott J Antonia
Novel therapies for renal cell carcinoma.
Expert opinion on investigational drugs 2001;10(6):1033-44.
2000: Scott J Antonia; John Seigne
B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma.
World journal of urology 2000;18(2):157-63.
2000: Scott J Antonia; Eduardo M Sotomayor
Gene therapy for lung cancer.
Current opinion in oncology 2000;12(2):138-42.
1999: R J Jackson; Scott J Antonia; Kenneth L Wright; Nam-Sung Moon; Alain Nepveu; Teresita Muñoz-Antonia
Human cut-like repressor protein binds TGFbeta type II receptor gene promoter.
Archives of biochemistry and biophysics 1999;371(2):290-300.
1999: Ronald Jennings; Teresita Muñoz-Antonia; Z Zhu; R Jackson; Scott J Antonia
Identification of an enhancer element in the mouse B7-1 promoter.
Immunogenetics 1999;50(1-2):109-12.
1998: Scott J Antonia; Martine Extermann; R A Flavell
Immunologic nonresponsiveness to tumors.
Critical reviews in oncogenesis 1998;9(1):35-41.